Dorsey & Whitney Trust’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-3,619
Closed -$359K 465
2019
Q3
$359K Buy
3,619
+73
+2% +$6.94K 0.05% 273
2019
Q2
$328K Sell
3,546
-189
-5% -$17.9K 0.05% 275
2019
Q1
$352K Buy
3,735
+231
+7% +$20.2K 0.06% 253
2018
Q4
$225K Buy
3,504
+100
+3% +$7.38K 0.04% 312
2018
Q3
$306K Buy
+3,404
New +$301K 0.05% 278
2018
Q1
Sell
-2,266
Closed -$237K 400
2017
Q4
$237K Buy
2,266
+148
+7% +$16.7K 0.04% 292
2017
Q3
$307K Buy
+2,118
New +$288K 0.06% 223
2016
Q4
Sell
-2,308
Closed -$243K 316
2016
Q3
$243K Buy
2,308
+111
+5% +$12K 0.06% 228
2016
Q2
$217K Buy
2,197
+69
+3% +$7.14K 0.05% 242
2016
Q1
$212K Sell
2,128
-138
-6% -$14.2K 0.05% 218
2015
Q4
$271K Buy
2,266
+158
+7% +$18.3K 0.07% 186
2015
Q3
$227K Buy
2,108
+176
+9% +$21.8K 0.06% 205
2015
Q2
$224K Sell
1,932
-117
-6% -$13.4K 0.06% 222
2015
Q1
$235K Buy
2,049
+87
+4% +$10.4K 0.06% 218
2014
Q4
$220K Sell
1,962
-437
-18% -$46.1K 0.06% 228
2014
Q3
$227K Buy
+2,399
New +$216K 0.06% 223
2014
Q2
Sell
-3,206
Closed -$223K 272
2014
Q1
$223K Sell
3,206
-398
-11% -$31.5K 0.05% 218
2013
Q4
$305K Sell
3,604
-260
-7% -$20.6K 0.08% 189
2013
Q3
$298K Buy
+3,864
New +$271K 0.09% 178

Other funds holding CELG

Dorsey & Whitney Trust's CELG Position: Q4 2019 in Review

Dorsey & Whitney Trust sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 3,619 shares — an estimated $359K sold.

Dorsey & Whitney Trust first reported a position in CELG in Q3 2013 and held it in 19 quarters. The position peaked at $359K in Q3 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Dorsey & Whitney Trust reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Dorsey & Whitney Trust sold 3,619 Celgene Corp shares in Q4 2019, an estimated $359K.
  • Dorsey & Whitney Trust first reported a position in Celgene Corp in Q3 2013 and held it in 19 quarters.
  • Dorsey & Whitney Trust's Celgene Corp position peaked at $359K in Q3 2019.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Dorsey & Whitney Trust's 13F filing for Q4 2019, filed 6 Feb 2020.